Innovator IBD ETF Leaders ETF
LDRS
LDRS was delisted on the 13th of August, 2021.
5 hedge funds and large institutions have $546K invested in Innovator IBD ETF Leaders ETF in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and 0 closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
3% more capital invested
Capital invested by funds: $531K → $546K (+$15K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$23 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$53.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$17.4K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$11.6K |
LDRS Hedge Fund Activity: Q3 2020 in Review
5 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q3 2020, worth a combined $546K — up 2.8% from $531K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new LDRS positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Wells Fargo, opening a new position worth an estimated $23. The largest seller was Citadel Advisors, cutting an estimated $53.2K.
- 5 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q3 2020, up from 4 in Q2 2020.
- Funds reported $546K of Innovator IBD ETF Leaders ETF stock for Q3 2020, up 2.8% quarter-over-quarter.
- 1 fund opened new Innovator IBD ETF Leaders ETF positions in Q3 2020 and 0 closed out, a net change of +1 holder.
- The largest Innovator IBD ETF Leaders ETF buyer in Q3 2020 was Wells Fargo, an estimated $23 added.
- The largest Innovator IBD ETF Leaders ETF seller in Q3 2020 was Citadel Advisors, an estimated $53.2K sold.
Based on aggregated 13F filings for Q3 2020.